Obermatt
See Similar Stocks →

Avantor

NYQ:AVTR · US05352A1007
Life Sciences Tools & ServicesX-Large

360

13
EV / EBIT94
Price / Owner Earnings86
Owner Earnings Yield1
Dividend Yield1
Price/Sales87
EV / Gross Profit91
Price/Book83
Return on Capital45
Cash Return on Capital35
Return on Equity24
EBIT Margin47
Gross Profitability47
Accruals79
Owner Earnings Margin37
Sales growth21
Profit Growth77
Long-Term EPS Growth15
Owner Earnings Growth8
Reinvestment40
Price momentum15
Debt load36
Refinancing89
Debt Payback1
Liquidity58
Analyst ratings7
Opinion Changes72
Price Target Upside13
Market mood25
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Avantor doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
TypePublic Company
ExchangeNYSE
Founded2017
Employees5,063
Websiteavantorsciences.com
ISINUS05352A1007
Last UpdateApr 2, 2026
Indices
S&P MIDCAP (USA)D.J. US Health Care
Themes
Health DiagnosticsBiotechnologyLife SciencePharmaceutical

Description

Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma and healthcare, education and government, and advanced technologies and applied materials end markets. The company’s business model is grounde…

Analysis

Bargain bin

Avantor, Inc. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

Valuation data is not available for this company.

Growth is weak; the safety picture is fragile. The company scores 4/20 on our value-creation score: not creating value.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
57
2023202420252026

All-time high

93

Jan 2023

All-time low

26

Jan 2024

Average rank

57

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
87
88
79
85
Price/Earnings
57
91
77
69
Price/Book
83
75
55
19
Dividend Yield
1
71
1
1
Value (overall)
85
100
74
63

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Avantor with its peers
Bruker
NSQ:BRKR
41
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Mesa Laboratories
NSQ:MLAB
69
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Mettler-Toledo
NYQ:MTD
53
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Waters
NYQ:WAT
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Rapid Micro Biosystems
NAQ:RPID
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Agilent
NYQ:A
89
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →